These 3 Under-the-Radar Stocks Have Triple-Digit Upside Potential – 12/5/2025

If you're looking for investment ideas right now, several top-rated Wall Street analysts believe that the following stocks are Buys with significant room to grow from current levels. In addition, you can click on any ticker below to explore the company in depth and decide whether it deserves a spot in your portfolio.TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off Absci (ABSI) Stock – Absci is a drug and target discovery company that provides biologic drug candidates and production cell lines using an integrated drug creation platform for partners in the United States. Analyst Debanjana Chatterjee from JonesTrading reiterated a Buy rating on the stock and maintained a price target of $9 per share. This equates to an upside of more than 151% from current levels. Groupon (GRPN) Stock – Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. Analyst Bobby Brooks from Northland Securities reiterated his Buy rating on the stock and maintained a price target of $42 per share. This equates to an upside of more than 136% from current levels. uniQure (QURE) Stock – uniQure N.V. is a gene therapy company based in the Netherlands that specializes in the development of innovative treatments for genetic diseases. Analyst Paul Matteis from Stifel Nicolaus assigned a Buy rating with a price target of $50 per share. This equates to an upside of more than 134% from current levels. To see the full list of recently rated stocks, visit TipRanks' Daily Stock Ratings & Price Targets tool.